Current Data on COVID-19 mRNA-Vaccine Safety during Pregnancy Might Be Subject to Selection Bias. Reply to Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on “Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199”

Viruses (Aug 2021)

Affiliations

Sarah Stuckelberger: Department Woman-Mother-Child, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland
Guillaume Favre: Department Woman-Mother-Child, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland
Michael Ceulemans: Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium
Eva Gerbier: Department Woman-Mother-Child, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland
Valentine Lambelet: Department Woman-Mother-Child, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland
Milos Stojanov: Department Woman-Mother-Child, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland
Ursula Winterfeld: Swiss Teratogen Information Service, Service de Pharmacologie Clinique, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland
David Baud: Department Woman-Mother-Child, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland
Alice Panchaud: Institute of Primary Health Care (BIHAM), University of Bern, 3012 Bern, Switzerland
Léo Pomar: Department Woman-Mother-Child, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland

Abstract

We would like to thank Stroobandt, S. and Stroobandt, R. for showing interest in our paper [...]